Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Brenda C.M. de Winter"'
Autor:
Midas B. Mulder, PharmD, Bart van Hoek, MD, PhD, Wojtek G. Polak, MD, PhD, Ian P.J. Alwayn, MD, PhD, Brenda C.M. de Winter, PharmD, PhD, Sarwa Darwish Murad, MD, PhD, Elke Verhey-Hart, BSc, Lara Elshove, MSc, Nicole S. Erler, Dipl-Stat, PhD, Dennis A. Hesselink, MD, PhD, Caroline M. den Hoed, MD, PhD, Herold J. Metselaar, MD, PhD
Publikováno v:
Transplantation Direct, Vol 10, Iss 4, p e1612 (2024)
Background. The aim of this open-label, multicenter, randomized controlled study was to investigate whether the life cycle pharma (LCP)-tacrolimus compared with the extended-release (ER)-tacrolimus formulation results in a difference in the prevalenc
Externí odkaz:
https://doaj.org/article/e000db20ac504b629c8bfe70cc940d02
Autor:
Suwasin Udomkarnjananun, Marith I. Francke, Marjolein Dieterich, Daan van De Velde, Nicolle H.R. Litjens, Karin Boer, Brenda C.M. De Winter, Carla C. Baan, Dennis A. Hesselink
Publikováno v:
Transplantation, 107(2), 382-391. Lippincott Williams & Wilkins
Background. Transplant recipients may develop rejection despite having adequate tacrolimus whole blood predose concentrations (C0). The intra-immune cellular concentration is potentially a better target than C0. However, little is known regarding int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6788f19ec0c3844373e78079a126e93
https://doi.org/10.1097/TP.0000000000004287
https://doi.org/10.1097/TP.0000000000004287
Autor:
Marith I. Francke, Bart van Domburg, Daan van de Velde, Dennis A. Hesselink, Brenda C.M. de Winter
Publikováno v:
Clinical Biochemistry, 104, 70-73. Elsevier Inc.
Dried blood spot (DBS) microsampling has several advantages over venous blood sampling. In a clinical validation study of tacrolimus microsampling it was noted that tacrolimus DBS concentrations ([Tac]DBS) were systematically higher than tacrolimus w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8279bd8ede4430bd84f139f04891035c
https://doi.org/10.1016/j.clinbiochem.2022.03.007
https://doi.org/10.1016/j.clinbiochem.2022.03.007
Autor:
Marith I. Francke, Bart van Domburg, Samah Bouarfa, Daan van de Velde, Merel E. Hellemons, Olivier C. Manintveld, Suzanne Last-Koopmans, Midas B. Mulder, Dennis A. Hesselink, Brenda C.M. de Winter
Publikováno v:
Clinica Chimica Acta, 535, 131-139. Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82531b71bf7b876a3fb07a374ab813fb
https://pure.eur.nl/en/publications/9037566b-760f-4f57-81c8-464c789ca73e
https://pure.eur.nl/en/publications/9037566b-760f-4f57-81c8-464c789ca73e
Publikováno v:
Journal of Pediatrics, 246, 284-285. Mosby Inc.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68dc9bba06530947299cd3b45fbcc358
https://pubmed.ncbi.nlm.nih.gov/35447122
https://pubmed.ncbi.nlm.nih.gov/35447122
Autor:
Birgit C.P. Koch, Qiaolin Zhao, Maartje Oosterhoff, Jakob van Oldenrijk, Alan Abdulla, Brenda C.M. de Winter, Koen Bos, Anouk E. Muller
Introduction Currently, antibiotic treatment is often a standard dosing regimen in bone and joint infections (BJI). However, it remains unknown if exposure at the target-site is adequate. The aim of this review is to gain more insight in the relation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b6e17e49cc4b8e23d807ebdaae27198